Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Intimation of Board Meeting to be held on 30.05.2025

pdf

Jeevan Scientific Technology Ltd.

30 Apr 2025

40.37

0.87%

Corp. Note

Jeevan Scientific Technology Ltd - 538837 - Format of the Annual Disclosure to be made by …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Jeevan Scientific Technology Ltd 2 CIN NO. L72200TG1999PLC031016 3 Report filed for FY 2024-2025 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2024-25, FY 2025-26 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) NA 8Quantum of (d), which has been met from (c)(e)* NA 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* NA Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2024-25, FY 2023-24 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Mr Krishna Sainadh KodatiDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Mr Venkateswara Rao Ravipati Designation : -CFO Date: 30/04/2025

pdf

Jeevan Scientific Technology Ltd.

30 Apr 2025

40.37

0.87%

Corp. Note

Jeevan Scientific Technology Ltd - 538837 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyJeevan Scientific Technology Ltd 2CIN NO.L72200TG1999PLC031016 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 7.67 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Mr Krishna Sainadh Kodati Designation: Company Secretary and Compliance Officer EmailId: sainadh.kodati@jeevanscintific.com Name of the Chief Financial Officer: Mr Venkateshwara Rao Ravipati Designation: CFO EmailId: venkat.ravipati@jeevanscientific.com Date: 30/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Jeevan Scientific Technology Ltd.

15 Apr 2025

40.37

0.87%

Company Update

Jeevan Scientific Technology Ltd - 538837 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance as per Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025.

pdf

Jeevan Scientific Technology Ltd.

09 Apr 2025

40.37

0.87%

Company Update

Jeevan Scientific Technology Ltd - 538837 - Information About Successful Completion Of Inspection Of JSTL Clinical …

BSE India

Information about successful completion of Inspection of JSTL Clinical and Bioanalytical facilities by CDSCO (Central Drugs Standard Control Organisation) under Regulation 30 of SEBI(LODR) Regulations, 2015.

pdf